Clinical Effectiveness of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Management of Renal Cell Carcinoma: A Single Institution Experience

WORLD JOURNAL OF NUCLEAR MEDICINE - Tập 14 Số 01 - Trang 36-40 - 2015
Aung Zaw Win1,2, Carina Marí Aparici1
1Department of Radiology, San Francisco VA Medical Center, San Francisco, CA 94121, USA
2Department of Radiology, University California San Francisco, San Francisco, CA 94143, USA

Tóm tắt

Positron emission tomography (PET) is currently the most advanced technique of metabolic imaging available for tumor diagnosis and follow-up. The aim of this study was to examine the versatility and accuracy of fluorodeoxyglucose (FDG) PET/computed tomography (CT) in the metastasis detection of renal cell carcinoma (RCC). We also compared our findings to other similar studies from the literature. This is the biggest study so far to examine the sensitivity and specificity of FDG PET/CT in the management of RCC. A retrospective review was carried out on all the FDG PET/CT studies done from January 1999 to January 2014 at our institution. Biopsy results were considered the gold standard. For our patients (n = 315) with biopsy results, FDG PET/CT studies exhibited 100% sensitivity, 100% specificity. Our results were better than results achieved by other studies. The use of FDG PET/CT in restaging and metastasis detection of RCC has many advantages, in addition to high accuracy. This imaging technique has great potential in influencing treatment decisions. We recommend the incorporation of FDG PET/CT in routine standard protocols for RCC.

Từ khóa


Tài liệu tham khảo

Jeon, 2010, J Urol, Prognostic value of body mass index in Korean patients with renal cell carcinoma, 448

Schöder, 2004, Semin Nucl Med, Positron emission tomography for prostate, bladder, and renal cancer, 274

Cote, 2012, Cancer Epidemiol Biomarkers Prev, Cigarette smoking and renal cell carcinoma risk among black and white Americans: Effect modification by hypertension and obesity, 770

Scher HI, Motzer RJ. Bladder and renal cell carcinomas. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison′s Principles of Internal Medicine. 16 th ed. New York: McGraw-Hill; 2005. p. 541-3.

Safaei, 2002, Clin Nephrol, The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer, 56

Khandani, 2012, Semin Nucl Med, Positron emission tomography in renal cell carcinoma: An imaging biomarker in development, 221

Liu, 2010, J Urol, Repeat partial nephrectomy on the solitary kidney: Surgical, functional and oncological outcomes, 1719

Press, 1984, AJR Am J Roentgenol, Papillary renal cell carcinoma: CT and sonographic evaluation, 1005

Li, 2012, J Cancer Res Clin Oncol, Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention, 269

Majhail, 2003, J Clin Oncol, F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma, 3995

Fuccio, 2014, Clin Nucl Med, Restaging clear cell renal carcinoma with 18F-FDG PET/CT, e320

Nakatani, 2011, Eur J Radiol, The potential clinical value of FDG-PET for recurrent renal cell carcinoma, 29

Kumar, 2010, Nucl Med Commun, Role of FDG PET-CT in recurrent renal cell carcinoma, 844

Rodríguez, 2010, Rev Esp Med Nucl, Clinical impact of (18) F-FDG PET in management of patients with renal cell carcinoma, 12

Park, 2009, BJU Int, Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma, 615

Dilhuydy, 2006, Oncology, PET scans for decision-making in metastatic renal cell carcinoma: A single-institution evaluation, 339

Jadvar, 2003, Clin Nephrol, Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma, 395

Ramdave, 2001, J Urol, Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma, 825

Fang, 2010, Arch Pathol Lab Med, Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp, 1003

Chung, 2012, Urol Oncol, Renal cell carcinoma with metastases to the gallbladder: Four cases from the National Cancer Institute (NCI) and review of the literature, 476

Patard, 2005, J Clin Oncol, Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience, 2763

Lee, 2012, BJU Int, Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC), E28

Powles, 2007, Eur Urol, Molecular positron emission tomography and PET/CT imaging in urological malignancies, 1511

Aide, 2003, Eur J Nucl Med Mol Imaging, Efficiency of [(18) F] FDG PET in characterising renal cancer and detecting distant metastases: A comparison with CT, 1236

Kochhar, 2010, J Med Imaging Radiat Oncol, Role of FDG PET/CT in imaging of renal lesions, 347

Schuster, 2004, AJR Am J Roentgenol, Papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT, 1402

Seto, 2000, Urology, Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan, 286

Wu, 2002, J Cancer Res Clin Oncol, Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - A preliminary report, 503

Kang, 2004, J Urol, Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma, 1806

Mueller-Lisse, 2010, World J Urol, Imaging of advanced renal cell carcinoma, 253

Garin, 2007, Br J Radiol, CT and MRI in fat-containing papillary renal cell carcinoma, e193

Grant, 2008, J Nucl Med, Skeletal PET with 18F-fluoride: Applying new technology to an old tracer, 68

Lam, 2005, J Urol, Renal cell carcinoma 2005: New frontiers in staging, prognostication and targeted molecular therapy, 1853